Normal Laboratory Reference Ranges for FSH, LH, Estradiol, and Progesterone
Normal reference values for reproductive hormones vary significantly by menstrual cycle phase, age, and laboratory assay method, but for reproductive-age women in the early follicular phase (days 3-6), expect FSH 1.5-10 IU/L, LH 2-10 IU/L, estradiol 20-80 pg/mL, and progesterone <1-2 ng/mL.
Critical Context: Laboratory Variability
The evidence strongly emphasizes that reference ranges are not standardized across laboratories and vary considerably based on assay methodology 1. This creates a significant clinical challenge—the same hormone value measured at different laboratories may be interpreted as normal or abnormal depending on the supplied reference range 1. Therefore, you must use your specific laboratory's validated reference ranges rather than relying on generic values.
Timing of Sample Collection Matters
Blood samples should be obtained during the early follicular phase (days 3-6 of the menstrual cycle) in the morning while fasting 1, 2. This timing is critical because:
- Hormone levels fluctuate dramatically throughout the menstrual cycle
- Individual pulsatile secretion creates high amplitude variations, particularly for LH
- The LH/FSH ratio varies from 0.2-1.7 in early follicular phase but increases to 0.3-3.5 in luteal phase 3
Reference Ranges by Menstrual Cycle Phase
Early Follicular Phase (Days 3-6):
- FSH: 1.5-10.3 IU/L 4, 2
- LH: 2-10 IU/L (typically lower than FSH in this phase) 4, 2
- Estradiol (E2): 20-80 pg/mL 2
- Progesterone: <1-2 ng/mL 2, 3
Mid-Luteal Phase:
- Progesterone: >6 nmol/L (approximately >2 ng/mL) indicates ovulation occurred 4
- Estradiol: Variable, but typically elevated compared to follicular phase
Pre-Ovulation Peak:
- Estradiol: 150-200 pg/mL per mature follicle 5
- LH and FSH: Both surge dramatically during this 24-48 hour window
Special Clinical Scenarios
Premature Ovarian Insufficiency (POI):
The diagnostic threshold has been lowered in recent years. FSH elevation beyond 25 IU/L in a young woman (outside the pre-ovulation peak) indicates POI, though levels often range 25-35 IU/L in autoimmune POI and average 37 IU/L (range 26-64) in idiopathic POI 5. A confirmatory repeat assay 1 month later is recommended 5.
Functional Hypothalamic Amenorrhea (FHA):
Characterized by low or low-normal LH, normal FSH (usually higher than LH), E2 <50 pg/mL, and progesterone <1 ng/mL 2. The acute gonadotropin response to GnRH stimulation remains preserved.
Polycystic Ovary Syndrome (PCOS):
An LH/FSH ratio >2.5 may suggest PCOS, but at least one-third of PCOS patients do not demonstrate this abnormality 1. The ratio alone should not be used diagnostically.
Critical Pitfalls to Avoid
Hormonal contraception interference: Women using combined estrogen-progestin contraception or macro-progestins will have falsely low FSH levels. Discontinue antigonadotropic treatment for at least 3 months before reassessment 5.
Single time-point measurements: Due to pulsatile secretion, a single measurement may be misleading. For establishing normal ranges in research contexts, averaging 2-3 samples taken 20 minutes apart provides more accuracy 1, 4, 6.
Assay method matters: Immunoradiometric assay (IRMA) and radioimmunoassay (RIA) methods yield different absolute values, though they correlate well 3, 6. Always compare results to the specific assay's reference range.
Age-related changes: FSH and LH gradually increase with age, even before menopause 7. SHBG also increases steadily after the neonatal period 8.
Clinical Application Algorithm
When interpreting reproductive hormone levels:
- Verify timing: Confirm sample was drawn days 3-6 of cycle, morning, fasting
- Check medication history: Rule out hormonal contraception or other antigonadotropic agents
- Use pattern recognition over absolute values: The constellation of hormone levels is more informative than individual values
- Consider repeat testing: If borderline or inconsistent with clinical picture, repeat in 1 month
- Know your laboratory: Use only laboratories with demonstrated proficiency in reproductive hormone assays and validated reference ranges 1
The evidence consistently demonstrates that reference ranges must be interpreted in clinical context rather than as rigid diagnostic thresholds, particularly given the substantial inter-laboratory variability that persists despite improved assay standardization 9, 10.